Podcast
MSL Talk: Tom Caravela, Tara Gonzalez
Leveraging Creativity to Break into Your First MSL Role
Summary
In this episode, Alec McCarthy shares his insights on breaking into the MSL field with a creative approach. He highlights the 70/30 rule for networking, emphasizing its importance for early-career professionals, and recounts his own journey to securing an MSL position. The discussion covers strategies for effective messaging, particularly when engaging with C-suite executives, and the value of LinkedIn Premium for MSLs. Alec also explores using publishing and scientific literature to enhance job applications, aligning work with personal values, and the significance of persistence and resilience in the job search. The episode concludes with actionable advice for aspiring MSLs.
My guest today is Alec McCarthy, Medical Science Liaison at Merz Asthetics, and we discuss how to leverage creativity to break into your first MSL role.
Alec shares…
👉 What the 70/30 rule is and what the process is about
👉 What is important for aspiring MSLs to get noticed
👉 How to approach companies that you are targeting
👉 What tools and resources to rely on during the search process
👉 Creative tips
Provide 5 keywords for SEO search separated by commas
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Tara Gonzalez
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
Article
J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret